Results 41 to 50 of about 229,798 (284)

Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. [PDF]

open access: yes, 2018
BACKGROUND: Although coronary computed tomographic angiography (CTA) improves diagnostic certainty in the assessment of patients with stable chest pain, its effect on 5-year clinical outcomes is unknown.
Adamson, Philip D.   +37 more
core   +6 more sources

Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris.

open access: yesCirculation Journal, 2015
Coronary spasm is involved in many clinical scenarios, such as stable angina, acute coronary syndrome, sudden cardiac death, non-ischemic cardiomyopathy, arrhythmia and syncope. In recent years, imaging tools such as computerized tomographic angiography,
P. Ong   +5 more
semanticscholar   +1 more source

Assessment of Patients Knowledge towards Angina Pectoris in Kirkuk City [PDF]

open access: yesمجلة الموصل للتمريض, 2015
Background and aim: Angina pectoris is a clinical syndrome usually characterized by episodes or paroxysms of pain or pressure in the anterior chest.
Younis Khider Baez
doaj   +1 more source

Variability of the Heart Rhythm as an Additional Marker for Determining Vegetative Functions in Patients with Chronic Cerebral Ischemia [PDF]

open access: yes, 2018
Aim. Practical cardiology is in constant search for non-invasive vascular risk markers. Heart rhythm reflects the body\u27s response to various stimuli of the external and internal environment. Heart rate variability (HRV) has a prognostic and diagnostic
Inhula, N. (Nataliia)
core   +2 more sources

Meta-analysis of death and myocardial infarction in the DEFINE-FLAIR and iFR-SWEDEHEART trials: a hypothesis generating note of caution [PDF]

open access: yes, 2017
In patients with coronary heart disease, revascularization can improve symptoms and in certain high-risk subgroups may improve prognosis. Coronary angiography provides anatomical information and the physiological significance of a stenosis can be ...
Berry, Colin   +2 more
core   +1 more source

Dr. Hans Kohn and the political takeover of the Berlin Medical Society by the National Socialist regime in 1933

open access: yesThe Anatomical Record, EarlyView.
Abstract To solidify their power over society, totalitarian regimes will usually eliminate any dissent, any perceived threats early on. These threats include not only political enemies but also educated and independent segments of society, such as professional associations.
Michael Hortsch
wiley   +1 more source

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. [PDF]

open access: yes, 2015
AimsThe mechanistic basis of the symptoms and signs of myocardial ischaemia in patients without obstructive coronary artery disease (CAD) and evidence of coronary microvascular dysfunction (CMD) is unclear.
Anderson, R David   +15 more
core   +1 more source

The Myofascial Continuum: Anatomical Insights Into Noncardiac Chest Pain

open access: yesClinical Anatomy, EarlyView.
ABSTRACT Angina, commonly known as chest pain, is the primary symptom of ischemic heart disease and can also present as pain in the neck, shoulder, jaw, arm, or back. Noncardiac chest pain (NCCP) is a common disorder with various causes, marked by recurrent chest pain that mimics ischemic heart pain.
Prabu Raja G   +3 more
wiley   +1 more source

ОЦЕНКА ВЛИЯНИЯ ПОЧЕЧНЫХ ФАКТОРОВ РИСКА НА ВЕРОЯТНОСТЬ РАЗВИТИЯ РЕЦИДИВА СТЕНОКАРДИИ У БОЛЬНЫХ, ПОДВЕРГШИХСЯ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА, ОПТИМИЗАЦИЯ МЕДИКАМЕНТОЗНОЙ ТЕРАПИИ

open access: yesАрхивъ внутренней медицины, 2012
The aim of the study was to estimate the impact of renal risk factors (RRF), as well as drug therapy in patients with coronary heart disease and indication for revascularization in the risk of recurrence of angina pectoris.
Е. С. Левицкая   +3 more
doaj   +1 more source

Efficacy profile of ivabradine in patients with heart failure plus angina pectoris [PDF]

open access: yes, 2016
Objectives: In the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT), slowing of the heart rate with ivabradine reduced cardiovascular death or heart failure hospitalizations among patients with systolic chronic heart ...
Borer, Jeffrey S.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy